Peer review reports
From: Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
| Original Submission | ||
|---|---|---|
| 18 Jun 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 13 Aug 2023 | Reviewed | Reviewer Report - Francisco Javier Parrondo García |
| 18 Aug 2023 | Reviewed | Reviewer Report |
| 12 Sep 2023 | Author responded | Author comments - Xun Zhuang |
| Resubmission - Version 3 | ||
| 12 Sep 2023 | Submitted | Manuscript version 3 |
| 13 Sep 2023 | Author responded | Author comments - Xun Zhuang |
| Resubmission - Version 4 | ||
| 13 Sep 2023 | Submitted | Manuscript version 4 |
| 14 Sep 2023 | Author responded | Author comments - Xun Zhuang |
| Resubmission - Version 5 | ||
| 14 Sep 2023 | Submitted | Manuscript version 5 |
| 14 Sep 2023 | Author responded | Author comments - Xun Zhuang |
| Resubmission - Version 6 | ||
| 14 Sep 2023 | Submitted | Manuscript version 6 |
| 16 Oct 2023 | Reviewed | Reviewer Report |
| 23 Oct 2023 | Reviewed | Reviewer Report - Francisco Javier Parrondo García |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 23 Oct 2023 | Editorially accepted | |
| 13 Nov 2023 | Article published | 10.1186/s12889-023-17052-1 |